Detalhe da pesquisa
1.
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma.
J Immunother Cancer
; 9(6)2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34117113
2.
Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
Stem Cells
; 26(2): 381-6, 2008 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-17975228
3.
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors.
J Immunother Cancer
; 6(1): 61, 2018 06 20.
Artigo
Inglês
| MEDLINE | ID: mdl-29921320
4.
Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses.
PLoS One
; 12(8): e0182683, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28787006
5.
Pancreatic cancer: Update on immunotherapies and algenpantucel-L.
Hum Vaccin Immunother
; 12(3): 563-75, 2016 03 03.
Artigo
Inglês
| MEDLINE | ID: mdl-26619245
6.
Algenpantucel-L immunotherapy in pancreatic adenocarcinoma.
Immunotherapy
; 8(2): 117-25, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26787078
7.
A phase I study of indoximod in patients with advanced malignancies.
Oncotarget
; 7(16): 22928-38, 2016 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-27008709
8.
Combination immunotherapy for high-risk resected and metastatic melanoma patients.
Ochsner J
; 14(2): 164-74, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24940124
9.
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors.
Oncotarget
; 5(18): 8136-46, 2014 Sep 30.
Artigo
Inglês
| MEDLINE | ID: mdl-25327557
10.
Cellular immunotherapy study of prostate cancer patients and resulting IgG responses to peptide epitopes predicted from prostate tumor-associated autoantigens.
J Immunother
; 36(1): 57-65, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23211622
11.
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan.
Oncoimmunology
; 1(9): 1460-1468, 2012 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23264892
12.
A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge.
Virology
; 397(1): 187-98, 2010 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-19932911
13.
Herpes simplex amplicon vectors.
Methods Mol Med
; 76: 61-87, 2003.
Artigo
Inglês
| MEDLINE | ID: mdl-12526159